PROCEPT BioRobotics (PRCT) EPS (Basic) Growth (3y) (2023 - 2026)
PROCEPT BioRobotics (PRCT) EPS (Basic) Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.94 Bn | 176.64 Bn | 6.27 Bn | -6.52% |
| 2 | Stryker | 128.78 Bn | 125.90 Bn | 3.81 Bn | 7.60% |
| 3 | Medtronic | 109.01 Bn | 99.79 Bn | 6.41 Bn | 3.18% |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn | 62.89% |
| 5 | Edwards Lifesciences | 47.66 Bn | 43.99 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.36 Bn | 26.07 Bn | 1.98 Bn | 29.37% |
| 7 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | 60.34% |
| 8 | Smith & Nephew | 26.93 Bn | 26.36 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | 30.65% |
| 10 | PROCEPT BioRobotics | 1.00 Bn | 758.28 Mn | 53.95 Mn | 31.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.34% |
| Dec 31, 2025 | -2.87% |
| Sep 30, 2025 | -7.17% |
| Jun 30, 2025 | -36.03% |
| Mar 31, 2025 | -0.20% |
| Dec 31, 2024 | 29.02% |
| Sep 30, 2024 | 24.23% |
| Jun 30, 2024 | 38.33% |
| Mar 31, 2024 | 32.53% |
| Dec 31, 2023 | 44.20% |
| Sep 30, 2023 | 39.85% |